SE0101230D0 - Ny användning av en tyrosinkinasinhibitor - Google Patents
Ny användning av en tyrosinkinasinhibitorInfo
- Publication number
- SE0101230D0 SE0101230D0 SE0101230A SE0101230A SE0101230D0 SE 0101230 D0 SE0101230 D0 SE 0101230D0 SE 0101230 A SE0101230 A SE 0101230A SE 0101230 A SE0101230 A SE 0101230A SE 0101230 D0 SE0101230 D0 SE 0101230D0
- Authority
- SE
- Sweden
- Prior art keywords
- tyrosine kinase
- frk
- inhibitor
- relates
- type
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/45—Transferases (2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Hematology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Obesity (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Priority Applications (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE0101230A SE0101230L (sv) | 2001-04-06 | 2001-04-06 | Ny användning av en tyrosinkinasinhibitor |
PCT/SE2002/000682 WO2002080894A1 (en) | 2001-04-06 | 2002-04-05 | Novel use of tyrosine kinase inhibitor |
EP02720710A EP1372621B1 (en) | 2001-04-06 | 2002-04-05 | Novel use of tyrosine kinase frk inhibitor |
US10/473,765 US20040171563A1 (en) | 2001-04-06 | 2002-04-05 | Novel use of tyrosine kinase inhibitor |
AT02720710T ATE397921T1 (de) | 2001-04-06 | 2002-04-05 | Neue verwendung von frk-tyrosinekinase inhibitoren |
DE60227058T DE60227058D1 (sv) | 2001-04-06 | 2002-04-05 | |
DK02720710T DK1372621T3 (da) | 2001-04-06 | 2002-04-05 | Hidtil ukendt anvendelse af tyrosinkinase-FRK-inhibitor |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE0101230A SE0101230L (sv) | 2001-04-06 | 2001-04-06 | Ny användning av en tyrosinkinasinhibitor |
Publications (2)
Publication Number | Publication Date |
---|---|
SE0101230D0 true SE0101230D0 (sv) | 2001-04-06 |
SE0101230L SE0101230L (sv) | 2002-10-07 |
Family
ID=20283697
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE0101230A SE0101230L (sv) | 2001-04-06 | 2001-04-06 | Ny användning av en tyrosinkinasinhibitor |
Country Status (7)
Country | Link |
---|---|
US (1) | US20040171563A1 (sv) |
EP (1) | EP1372621B1 (sv) |
AT (1) | ATE397921T1 (sv) |
DE (1) | DE60227058D1 (sv) |
DK (1) | DK1372621T3 (sv) |
SE (1) | SE0101230L (sv) |
WO (1) | WO2002080894A1 (sv) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060094682A1 (en) * | 2004-10-29 | 2006-05-04 | Odyssey Thera, Inc. | Kinase inhibitors for the treatment of diabetes and obesity |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6177401B1 (en) * | 1992-11-13 | 2001-01-23 | Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften | Use of organic compounds for the inhibition of Flk-1 mediated vasculogenesis and angiogenesis |
US5880141A (en) * | 1995-06-07 | 1999-03-09 | Sugen, Inc. | Benzylidene-Z-indoline compounds for the treatment of disease |
GB9718913D0 (en) * | 1997-09-05 | 1997-11-12 | Glaxo Group Ltd | Substituted oxindole derivatives |
GB9721437D0 (en) * | 1997-10-10 | 1997-12-10 | Glaxo Group Ltd | Heteroaromatic compounds and their use in medicine |
US6777417B2 (en) * | 2001-09-10 | 2004-08-17 | Sugen, Inc. | 3-(4,5,6,7-tetrahydroindol-2-ylmethylidiene-2-indolinone derivatives as kinase inhibitors |
-
2001
- 2001-04-06 SE SE0101230A patent/SE0101230L/sv not_active Application Discontinuation
-
2002
- 2002-04-05 AT AT02720710T patent/ATE397921T1/de not_active IP Right Cessation
- 2002-04-05 US US10/473,765 patent/US20040171563A1/en not_active Abandoned
- 2002-04-05 WO PCT/SE2002/000682 patent/WO2002080894A1/en not_active Application Discontinuation
- 2002-04-05 DE DE60227058T patent/DE60227058D1/de not_active Expired - Fee Related
- 2002-04-05 DK DK02720710T patent/DK1372621T3/da active
- 2002-04-05 EP EP02720710A patent/EP1372621B1/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
DK1372621T3 (da) | 2008-10-20 |
ATE397921T1 (de) | 2008-07-15 |
SE0101230L (sv) | 2002-10-07 |
US20040171563A1 (en) | 2004-09-02 |
EP1372621B1 (en) | 2008-06-11 |
WO2002080894A1 (en) | 2002-10-17 |
DE60227058D1 (sv) | 2008-07-24 |
EP1372621A1 (en) | 2004-01-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUP0402403A2 (hu) | Cukorbetegség-ellenes hatású dipeptilpeptidáz IV (DP-IV) inhibitorok ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk | |
NO20083026L (no) | Terapeutisk middel for diabetes | |
UA88257C2 (ru) | ПРИМЕНЕНИЕ ИНГИБИТОРА ПРОТЕИНКИНАЗЫ С-α ДЛЯ ЛЕЧЕНИЯ ЗАБОЛЕВАНИЙ ПОЧЕК, КОТОРЫЕ ПРИВОДЯТ К ПРОТЕИНУРИИ, И ДИАБЕТИЧЕСКИМ РЕТИНОПАТИИ, НЕВРОПАТИИ ИЛИ НЕФРОПАТИИ | |
Wangpu et al. | Targeting the metastasis suppressor, N-Myc downstream regulated gene-1, with novel di-2-pyridylketone thiosemicarbazones: Suppression of tumor cell migration and cell-collagen adhesion by inhibiting focal adhesion kinase/paxillin signaling | |
IS7753A (is) | Beta-amínó heterósýklískir dípeptidýl peptíðasa hindrar til meðhöndlunar á, eða til að fyrirbyggja,sykursýki | |
AU2003282234A1 (en) | Benzofuran derivates, process for their preparation and intermediates thereof | |
MY127961A (en) | Beta-amino heterocyclic dipetidyl peptidase inhibitors for the treament or prevention of diabetes | |
HUP0401998A2 (hu) | PDE9 inhibitorok alkalmazása olyan gyógyszer előállítására, amellyel inzulin-rezisztencia szindróma és 2-es típusú diabétesz kezelhető | |
DE60231407D1 (de) | Hemmende antikörper der her3-aktivität | |
NO20063351L (no) | Heteroarylureaer og deres anvendelse som glukokinase aktivatorer | |
MXPA03011083A (es) | Compuestos de sulfonamida sustituida, procedimiento para su preparacion, y su uso como medicamento para el tratamiento de trastornos del sistema nervioso central. obesidad y diabetes tipo ii. | |
MXPA03010232A (es) | Compuestos de arilsulfonamida, para el tratamiento de la obesidad, de la diabetes tipo ii y de trastornos del sistema nervioso central. | |
NO20091596L (no) | Benzoylamino-heterocykliske forbindelser som Glucokinase-(GLK)-activatorer | |
MXPA04003759A (es) | Derivados de pirrolidin n-substituido como inhibidores de dipeptidil peptidasa iv. | |
WO2010029089A3 (en) | Combination therapy for the treatment of diabetes and related conditions | |
DE60110054D1 (en) | Cardioprotektive phosphonate | |
EA201100097A1 (ru) | Производные пиразоло[3,4]пиримидин-4-ила и их применения для лечения диабета и ожирения | |
ATE358668T1 (de) | Drogen zur behandlung maligner tumoren | |
EA201300550A1 (ru) | Фармацевтическая композиция, способы лечения и их применение | |
NO20034204L (no) | Farmasöytiske kombinasjoner til behandling av kreft | |
HUP0402506A2 (hu) | FBPáz inhibitorok és inzulinérzékenység-fokozók kombinációja diabétesz kezelésére | |
HUP0402421A2 (hu) | Mátrix-metalloproteinázokat gátló készítmény neopláziás betegségek kezelésére | |
DK1599732T3 (da) | Fremgangsmåde og præparater til behandling af diagnosticering af diabetes og dermed beslægtede sygdomme som involverer beta-TRP | |
WO2006039343A3 (en) | Emmprin antagonists and uses thereof | |
BR0316523A (pt) | Composto, composição farmacêutica e método para tratar ou prevenir câncer em um paciente |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
NAV | Patent application has lapsed |